About the journal
Experimental Hematology & Oncology is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,990 EUR. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMC
- ISSN
- 2162-3619
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,990 EUR
- Articles in DOAJ
- 793
- Declared review time
- 6 weeks
- Declared peer-review model
- peer_review
- Official website
- https://ehoonline.biomedcentral.com
Index listings
- DOAJ · 2012-06-05
- PUBMED · 2012-03-26
- Indexing
- DOAJ · PUBMED
- APC
- 2,990 EUR
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
793
Most recent article
last month
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
904
Last recorded publication year
2026
h-index
74
i10-index
554
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2012-06-05
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 6%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Experimental hematology and oncology
- Source type
- journal
- NLM unique ID (PubMed)
- 101590676
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- CAR-T cell therapy research
- CAR-T cell therapy research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
Show all subjects (50)
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune cells in cancer
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Ferroptosis and cancer prognosis
- Virus-based gene therapy research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Virus-based gene therapy research
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Ferroptosis and cancer prognosis
- Histone Deacetylase Inhibitors Research
- Histone Deacetylase Inhibitors Research
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Hematopoietic Stem Cell Transplantation
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Hematopoietic Stem Cell Transplantation
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- RNA modifications and cancer
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- RNA modifications and cancer
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
Keywords (DOAJ)
- haematology
- oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ